PEMPHIGUS
Clinical trials for PEMPHIGUS explained in plain language.
Never miss a new study
Get alerted when new PEMPHIGUS trials appear
Sign up with your email to follow new studies for PEMPHIGUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blistering disease: drug may tame pemphigus without high steroid doses
Disease control Recruiting nowThis study tests an experimental drug called ONO-4059 for people with pemphigus, a rare autoimmune disease that causes painful blisters on skin and mucous membranes. It is for patients whose disease is not well controlled by steroids alone. The goal is to see if adding ONO-4059 c…
Matched conditions: PEMPHIGUS
Phase: PHASE3 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for pemphigus patients: B007 aims for remission with less medication
Disease control Recruiting nowThis study tests a new drug, B007, in 132 people with pemphigus, a serious blistering skin disease. The goal is to see if B007 can help patients achieve complete remission while needing only minimal ongoing treatment. The trial is for newly diagnosed or relapsed patients and will…
Matched conditions: PEMPHIGUS
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Smart antibody monitoring could slash pemphigus Flare-Ups
Disease control Recruiting nowThis study compares a personalized maintenance therapy for pemphigus, where rituximab is given based on antibody levels, against the standard treatment of rituximab plus corticosteroids. About 133 adults with newly diagnosed moderate-to-severe pemphigus will take part. The goal i…
Matched conditions: PEMPHIGUS
Phase: PHASE4 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
New study to measure hidden toll of rare skin diseases on patients and families
Knowledge-focused Recruiting nowThis study aims to understand how 9 rare skin diseases affect people's lives beyond just physical symptoms. Researchers will survey 900 patients and their families to measure the emotional, social, and financial burden. The goal is to create a tool that helps doctors and caregive…
Matched conditions: PEMPHIGUS
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 04, 2026 16:30 UTC